MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$630,900K
Net Income
-$92,900K
Net Profit Margin
-14.72%
EPS
-$1.36
Unit: Thousand (K) dollars
Revenue Breakdown
Labs
Immunohematology
Point Of Care
Others
Revenue Breakdown
North America Segment
EMEASegment
JPACSegment
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-28
2026-03-29
2025-12-28
2025-09-28
Total revenues
630,900
619,800
723,600
699,900
Cost of sales, excluding amortization of intangibles
358,000
356,000
403,200
364,300
Selling, marketing and administrative
189,700
199,300
194,400
186,900
Research and development
48,700
44,900
45,800
41,500
Amortization of intangible assets
49,000
46,800
45,600
47,700
Restructuring, integration and other charges
6,500
4,400
-64,150*
39,600
Goodwill impairment charge
-
-
98,000*
700,700
Asset impairment charge
-
-
-4,850*
9,700
Other operating expenses
800
200
71,900
14,300
Operating loss
-21,800
-31,800
-66,300
-704,800
Interest expense, net
54,700
51,100
51,000
46,100
Gain on extinguishment of debt
-
-
0
-5,100
Other expense, net
-4,700
3,400
4,900
-900
Loss before income taxes
-81,200
-79,500
-112,400
-756,900
Provision for income taxes
11,700
12,300
18,300
-23,900
Net loss
-92,900
-91,800
-130,700
-733,000
Basic EPS
-1.36
-1.35
-1.922
-10.78
Diluted EPS
-1.36
-1.35
-1.922
-10.78
Basic Average Shares
68,300,000
68,200,000
68,000,000
68,000,000
Diluted Average Shares
68,300,000
68,200,000
68,000,000
68,000,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net loss
-$92,900K
(63.63%↑ Y/Y)
Loss before income
taxes
-$81,200K
(64.63%↑ Y/Y)
Provision for income taxes
$11,700K
(-54.65%↓ Y/Y)
Labs
$382,900K
(3.57%↑ Y/Y)
Immunohematology
$134,200K
(1.44%↑ Y/Y)
Point Of Care
$108,200K
(16.34%↑ Y/Y)
Donor Screening
$4,000K
(-69.92%↓ Y/Y)
Molecular Diagnostics
$1,600K
(-71.43%↓ Y/Y)
Interest expense, net
$54,700K
(35.06%↑ Y/Y)
Operating loss
-$21,800K
(87.94%↑ Y/Y)
Other expense, net
-$4,700K
(44.05%↑ Y/Y)
Total revenues
$630,900K
(2.77%↑ Y/Y)
Cost of sales,
excluding amortization of...
$358,000K
(5.60%↑ Y/Y)
Selling, marketing and
administrative
$189,700K
(6.57%↑ Y/Y)
Amortization of intangible
assets
$49,000K
(2.30%↑ Y/Y)
Research and development
$48,700K
(6.56%↑ Y/Y)
Restructuring, integration and
other charges
$6,500K
(-96.37%↓ Y/Y)
Other operating
expenses
$800K
(-84.31%↓ Y/Y)
Buy us a coffee
QuidelOrtho Corp (QDEL)
QuidelOrtho Corp (QDEL)